Tracked deals
4
4 tracked deals across 2021-2024.
Operating Company
Healthcare
Precision Medicine Group
Bethesda, Maryland, United States
Life-sciences services company focused on biomarker-driven clinical research and development, providing clinical operations, laboratory and data-science capabilities to support drug development and commercialization. (Website indicates Precision is part of an acquisition/brand umbrella and includes business units such as Precision for Medicine, Precision Oncology, and QuartzBio.)
- Focus Areas
- Biomarker-driven clinical research, Clinical operations, Laboratory services
- Website
- precisionmedicinegrp.com
Recent pace
0
0 tracked deals announced in the last 12 months.
Deal mix
Buyout
4 buyout
Precision Medicine Group Acquisition Volume by Year
Last 3 years
Supporting Data
Recent Transactions
-
May 29, 2024
- Buyer
- Precision for Medicine
- Target
- Algorics
- Industry
- Healthcare Services
- Location
- Telangana, India
- Type
- Buyout
Precision for Medicine has acquired Algorics, a clinical technologies and biometrics services provider, adding two proprietary platforms (MetaVate and Clarity) and bolstering its clinical data management, biostatistics and statistical programming capabilities. The deal also expands Precision for Medicine's operational footprint in the Asia‑Pacific region and integrates Algorics' team into Precision's biometrics organization.
-
June 27, 2023
- Buyer
- Precision for Medicine
- Target
- Baseline Controls
- Industry
- Healthcare Services
- Location
- North Carolina, United States
- Type
- Buyout
Precision for Medicine has acquired Baseline Controls, a Raleigh-based project controls and project management firm, and will integrate its capabilities into Project Farma to broaden end-to-end biomanufacturing solutions for life science companies. The acquisition expands Precision for Medicine’s technical operations and project planning expertise—targeting faster, more cost-efficient manufacturing for small molecule, biologics and next-generation therapies including cell and gene therapy.
-
January 24, 2023
- Buyer
- QuartzBio (part of Precision for Medicine), Precision for Medicine
- Target
- SolveBio
- Industry
- Cloud & SaaS
- Location
- United States
- Type
- Buyout
QuartzBio, a business unit of Precision for Medicine, has acquired SolveBio and integrated its enterprise biomarker and genomic data management platform into QuartzBio’s end-to-end SaaS suite. The acquisition expands QuartzBio’s capabilities for sample inventory, biomarker data management and enterprise-level visibility to better serve pharmaceutical and biotech clients in clinical research and development.
-
January 14, 2021
- Buyer
- Precision Medicine Group
- Target
- Project Farma
- Industry
- Healthcare Services
- Location
- Connecticut, United States
- Type
- Buyout
Precision Medicine Group has acquired Project Farma, a bioengineering services firm specializing in biomanufacturing strategy and facility implementation with a focus on cell and gene therapies. The deal brings Project Farma's manufacturing and scale-up expertise into Precision's cell and gene therapy services (Precision ADVANCE) to expand end-to-end development, manufacturing, and commercialization capabilities.
Related Acquisition Pages
Healthcare Services Buyers & Acquisitions
3 tracked deals by Precision Medicine Group.
Cloud & SaaS Buyers & Acquisitions
1 tracked deal by Precision Medicine Group.
Acquisitions in Connecticut
1 tracked deal by Precision Medicine Group.
Acquisitions in North Carolina
1 tracked deal by Precision Medicine Group.
Selling a company? Get in front of buyers like Precision Medicine Group
Turn tracked acquisition activity into an outreach-ready buyer list.